Christopher J Bungard

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Michael T Rudd, Peter J Manley, Barbara Hanney, Zhaoyang Meng, Youheng Shu, Pablo de Leon, Jessica L Frie, Yongxin Han, Jenny Miu-Chun Wai, Zhi-Qiang Yang, James J Perkins, Danielle M Hurzy, Jesse J Manikowski, Hong Zhu, Christopher J Bungard, Antonella Converso, Robert S Meissner, Mali L Cosden, Ikuo Hayashi, Lei Ma, Julie O'Brien, Victor N Uebele, Joel B Schachter, Neetesh Bhandari, Gwendolyn J Ward, Kerry L Fillgrove, Bing Lu, Yuexia Liang, David C Dubost, Vanita Puri, Donnie M Eddins, Joshua D Vardigan, Robert E Drolet, Jonathan T Kern, Jason M Uslaner
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator. ACS medicinal chemistry letters 14 (8) (2023)
James J Perkins, Paul McQuade, Christopher J Bungard, Tracy L Diamond, Liza T Gantert, Anthony L Gotter, Barbara Hanney, Ivory D Hills, Danielle M Hurzy, Aniket Joshi, Jonathan T Kern, Kelly-Ann S Schlegel, Jesse J Manikowski, Zhaoyang Meng, Julie A O'Brien, Anthony J Roecker, Sean M Smith, Jason M Uslaner, Eric Hostetler, Robert S Meissner
Discovery of [ 11 C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR 2 Negative Allosteric Modulators. ACS medicinal chemistry letters 14 (7) (2023)

Christopher J Bungard.css-eqlu8i{font-size:small;padding-left:4px;}